|
|
||||||||
a Cellular Technology Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan;
b First Department of Pathology,
c Department of Pediatrics,
d Department of Obstetrics and Gynecology, Kansai Medical University, Moriguchi City, Osaka, Japan
Key Words. c-kit • CD34 • Human cord blood • Hematopoietic stem cells
Dr. Susumu Ikehara, First Department of Pathology, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi City, Osaka 570, Japan.
c-kit, a receptor for stem cell factor, has been widely accepted as a distinctive marker for hematopoietic stem cells. However, the level of c-kit expression on pluripotent hematopoietic stem cells is still controversial in mice and humans. We purified CD34+/c-kit<low cells (phenotypically c-kit-negative but only detectable at the message level) from human cord blood and examined their maturational steps in relation to the expression of c-kit molecules. When the CD34+/c-kit<low cells were cultured with cytokines (flt 3 ligand, interleukin 6 and interleukin 7) plus immobilized anti-CD34 monoclonal antibody (to crosslink CD34 molecules), c-kit molecules were clearly induced within 24 h. The c-kit expression gradually increased until day 8. When CD34+/c-kitlow or CD34+/c-kit+ cells that had been induced from CD34+/c-kit<low cells were resorted and recultured using a methylcellulose culture system, they showed the same colony-forming ability as the freshly isolated CD34+/c-kitlow or CD34+/c-kit+ cells, respectively. Furthermore, CD34+/c-kit<low cells have a similar hematopoietic potential to CD34+/c-kitlow cells in assays for long-term culture initiating cell and colony-forming unit culture generated from long-term cultures. These findings suggest that CD34+/c-kit<low cells mature into CD34+/c-kitlow and CD34+/c-kit+ cells, and acquire the reactivity to various humoral hematopoietic stimuli. Moreover, CD34+/c-kit<low cells showed a low level of rhodamine 123 retention, suggesting that CD34+/c-kit<low cells have multidrug resistance. Therefore, the CD34+/c-kit<low cells without colony-forming unit-granulocyte-erythroid-macrophage-megakaryocyte activity are also a pluripotent hematopoietic stem cell population, and the expression of c-kit on c-kit<low cells is the first maturational step of hematopoiesis.
This article has been cited by other articles:
![]() |
T. Kimura, R. Asada, J. Wang, T. Kimura, M. Morioka, K. Matsui, K. Kobayashi, K. Henmi, S. Imai, M. Kita, et al. Identification of Long-Term Repopulating Potential of Human Cord Blood-Derived CD34-flt3- Severe Combined Immunodeficiency-Repopulating Cells by Intra-Bone Marrow Injection Stem Cells, June 1, 2007; 25(6): 1348 - 1355. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Matsumura-Takeda, S. Sogo, Y. Isakari, Y. Harada, K. Nishioka, T. Kawakami, T. Ono, and T. Taki CD41+/CD45+ Cells Without Acetylcholinesterase Activity Are Immature and a Major Megakaryocytic Population in Murine Bone Marrow Stem Cells, April 1, 2007; 25(4): 862 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Yang, H. Hisha, Y. Cui, T. Fan, T. Jin, Q. Li, Z. Lian, N. Hosaka, Y. Li, and S. Ikehara A New Assay Method for Late CFU-S Formation and Long-Term Reconstituting Activity Using a Small Number of Pluripotent Hemopoietic Stem Cells Stem Cells, May 1, 2002; 20(3): 241 - 248. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ikehara Pluripotent Hemopoietic Stem Cells in Mice and Humans Experimental Biology and Medicine, February 1, 2000; 223(2): 149 - 155. [Abstract] [Full Text] |
||||
![]() |
B. Feng, M. Inaba, Z. Lian, Y. Cui, J. Toki, T. Ito, T. Jin, T. Fan, G. Yang, C. Yu, et al. Development of Mouse Dendritic Cells from Lineage-Negative c-kit‹low Pluripotent Hemopoietic Stem Cells In Vitro Stem Cells, January 1, 2000; 18(1): 53 - 60. [Abstract] [Full Text] |
||||
![]() |
S. Reid, A. Ritchie, L. Boring, J. Gosling, S. Cooper, G. Hangoc, I. F. Charo, and H. E. Broxmeyer Enhanced Myeloid Progenitor Cell Cycling and Apoptosis in Mice Lacking the Chemokine Receptor, CCR2 Blood, March 1, 1999; 93(5): 1524 - 1533. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Lian, B. Feng, K. Sugiura, M. Inaba, C. Yu, T. Jin, T. Fan, Y. Cui, R. Yasumizu, J. Toki, et al. c-kit Stem Cells, January 1, 1999; 17(1): 39 - 44. [Abstract] [Full Text] |
||||
![]() |
C.-Z. Yu, H. Hisha, Y. Li, Z. Lian, T. Nishino, J. Toki, Y. Adachi, M. Inaba, T.-X. Fan, T. Jin, et al. Stimulatory Effects of Hepatocyte Growth Factor on Hemopoiesis of SCF/c-kit System-Deficient Mice Stem Cells, January 1, 1998; 16(1): 66 - 77. [Abstract] [Full Text] |
||||
![]() |
Z. Lian, J. Toki, C. Yu, H. Hayashi, R. Yasumizu, K. Sugiura, T. Jin, M. Inaba, H. Hisha, Y. Li, et al. Intrathymically Injected Hemopoietic Stem Cells Can Differentiate into All Lineage Cells in the Thymus: Differences Between c-kit+ Cells and c-kit Stem Cells, November 1, 1997; 15(6): 430 - 436. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
